Entropy as the predominant driving force of binding to human recombinant αxβ3γ2 GABAA receptors

G. Maksay, Ruth McKernan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

In order to study the correlation of the thermodynamic driving forces of binding with the efficacies of displacing ligands, the specific binding of [3H]SR 95531 [2-(3-carboxypropyl)3-amino-6-p-methoxyphenylpyridazinium bromide], a GABAA receptor antagonist, was studied in cell lines stably expressing human α1β3γ2 and α2β3γ2 GABAA receptors. Displacing potencies for the agonists with different efficacies (muscimol, 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP) and piperidine-4-sulfonic acid) and for antagonists (SR 95531 and 5-(4-piperidyl)isothiazol-3-ol) were determined at 0°C, 20°C and 37°C. Displacing potencies were temperature-nearly independent for α1β3γ2 receptors. At α2β3γ2, receptor binding of the antagonists was exothermic, endothermic for the agonists THIP and piperidine-4-sulfonic acid and isothermic for muscimol. The free energy increments of displacement for the binding of the antagonist [3H]SR 95531 versus the agonist [3H]muscimol approach saturation as a function of the efficacies of the displacers only for α1β3γ2 receptors. This suggests that, for binding to α1β3γ2 GABAA receptors, displacement is an efficacy-dependent interaction predominantly driven by entropic increases.

Original languageEnglish
Pages (from-to)55-60
Number of pages6
JournalEuropean Journal of Pharmacology
Volume411
Issue number1-2
DOIs
Publication statusPublished - 2001

Fingerprint

Muscimol
Entropy
GABA-A Receptors
GABA-A Receptor Antagonists
Bromides
Thermodynamics
Ligands
Cell Line
Temperature
gabazine
gaboxadol
piperidine-4-sulfonic acid

Keywords

  • Entropy change
  • GABA receptor agonist
  • GABA receptor antagonist
  • GABA receptors
  • Recombinant
  • Thermodynamics

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Entropy as the predominant driving force of binding to human recombinant αxβ3γ2 GABAA receptors. / Maksay, G.; McKernan, Ruth.

In: European Journal of Pharmacology, Vol. 411, No. 1-2, 2001, p. 55-60.

Research output: Contribution to journalArticle

@article{18139fcec65f43a9934a24697bf6b10b,
title = "Entropy as the predominant driving force of binding to human recombinant αxβ3γ2 GABAA receptors",
abstract = "In order to study the correlation of the thermodynamic driving forces of binding with the efficacies of displacing ligands, the specific binding of [3H]SR 95531 [2-(3-carboxypropyl)3-amino-6-p-methoxyphenylpyridazinium bromide], a GABAA receptor antagonist, was studied in cell lines stably expressing human α1β3γ2 and α2β3γ2 GABAA receptors. Displacing potencies for the agonists with different efficacies (muscimol, 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP) and piperidine-4-sulfonic acid) and for antagonists (SR 95531 and 5-(4-piperidyl)isothiazol-3-ol) were determined at 0°C, 20°C and 37°C. Displacing potencies were temperature-nearly independent for α1β3γ2 receptors. At α2β3γ2, receptor binding of the antagonists was exothermic, endothermic for the agonists THIP and piperidine-4-sulfonic acid and isothermic for muscimol. The free energy increments of displacement for the binding of the antagonist [3H]SR 95531 versus the agonist [3H]muscimol approach saturation as a function of the efficacies of the displacers only for α1β3γ2 receptors. This suggests that, for binding to α1β3γ2 GABAA receptors, displacement is an efficacy-dependent interaction predominantly driven by entropic increases.",
keywords = "Entropy change, GABA receptor agonist, GABA receptor antagonist, GABA receptors, Recombinant, Thermodynamics",
author = "G. Maksay and Ruth McKernan",
year = "2001",
doi = "10.1016/S0014-2999(00)00898-0",
language = "English",
volume = "411",
pages = "55--60",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Entropy as the predominant driving force of binding to human recombinant αxβ3γ2 GABAA receptors

AU - Maksay, G.

AU - McKernan, Ruth

PY - 2001

Y1 - 2001

N2 - In order to study the correlation of the thermodynamic driving forces of binding with the efficacies of displacing ligands, the specific binding of [3H]SR 95531 [2-(3-carboxypropyl)3-amino-6-p-methoxyphenylpyridazinium bromide], a GABAA receptor antagonist, was studied in cell lines stably expressing human α1β3γ2 and α2β3γ2 GABAA receptors. Displacing potencies for the agonists with different efficacies (muscimol, 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP) and piperidine-4-sulfonic acid) and for antagonists (SR 95531 and 5-(4-piperidyl)isothiazol-3-ol) were determined at 0°C, 20°C and 37°C. Displacing potencies were temperature-nearly independent for α1β3γ2 receptors. At α2β3γ2, receptor binding of the antagonists was exothermic, endothermic for the agonists THIP and piperidine-4-sulfonic acid and isothermic for muscimol. The free energy increments of displacement for the binding of the antagonist [3H]SR 95531 versus the agonist [3H]muscimol approach saturation as a function of the efficacies of the displacers only for α1β3γ2 receptors. This suggests that, for binding to α1β3γ2 GABAA receptors, displacement is an efficacy-dependent interaction predominantly driven by entropic increases.

AB - In order to study the correlation of the thermodynamic driving forces of binding with the efficacies of displacing ligands, the specific binding of [3H]SR 95531 [2-(3-carboxypropyl)3-amino-6-p-methoxyphenylpyridazinium bromide], a GABAA receptor antagonist, was studied in cell lines stably expressing human α1β3γ2 and α2β3γ2 GABAA receptors. Displacing potencies for the agonists with different efficacies (muscimol, 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP) and piperidine-4-sulfonic acid) and for antagonists (SR 95531 and 5-(4-piperidyl)isothiazol-3-ol) were determined at 0°C, 20°C and 37°C. Displacing potencies were temperature-nearly independent for α1β3γ2 receptors. At α2β3γ2, receptor binding of the antagonists was exothermic, endothermic for the agonists THIP and piperidine-4-sulfonic acid and isothermic for muscimol. The free energy increments of displacement for the binding of the antagonist [3H]SR 95531 versus the agonist [3H]muscimol approach saturation as a function of the efficacies of the displacers only for α1β3γ2 receptors. This suggests that, for binding to α1β3γ2 GABAA receptors, displacement is an efficacy-dependent interaction predominantly driven by entropic increases.

KW - Entropy change

KW - GABA receptor agonist

KW - GABA receptor antagonist

KW - GABA receptors

KW - Recombinant

KW - Thermodynamics

UR - http://www.scopus.com/inward/record.url?scp=0035190525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035190525&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(00)00898-0

DO - 10.1016/S0014-2999(00)00898-0

M3 - Article

VL - 411

SP - 55

EP - 60

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-2

ER -